Starting soon, the 16th World ADC London (23rd–26th February), the longest-standing and pre-eminent ADC-focused forum in Europe, serves as the definitive one-stop shop for the European ADC community to harness next-generation innovation and maximise the therapeutic index of ADCs.
Starting soon, the 16th World ADC London (23rd–26th February), the longest-standing and pre-eminent ADC-focused forum in Europe, serves as the definitive one-stop shop for the European ADC community to harness next-generation innovation and maximise the therapeutic index of ADCs.
Designed for both newcomers and experienced professionals, the event features 5 streams of end-to-end content covering the latest scientific and technical advances. Discover innovations in cytotoxic and non-cytotoxic payloads, dual-payload and bispecific ADCs, non-antibody conjugates, and more, focused on overcoming resistance mechanisms and advancing ADCs into earlier lines of oncology treatment.